Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
about
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TBPulmonary Tuberculosis Diagnosis: Where We Are?Do the tuberculin skin test and the QuantiFERON-TB Gold in-tube test agree in detecting latent tuberculosis among high-risk contacts? A systematic review and meta-analysisEuropean union standards for tuberculosis careDiagnosis and treatment of latent infection with Mycobacterium tuberculosisFrequent detection of latent tuberculosis infection among aged underground hard coal miners in the absence of recent tuberculosis exposureA Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort StudyEvaluation of the filter paper IP-10 tests in school children after exposure to tuberculosis: a prospective cohort study with a 4-year follow-upCorrelation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden settingScreening of healthcare workers for tuberculosis: development and validation of a new health economic model to inform practiceThe biology of mycobacterium tuberculosis infection.Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis.Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosisTuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-γ release assay and tuberculin skin test.Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus.Diagnosis of latent tuberculosis in patients with systemic lupus erythematosus: T.SPOT.TB versus tuberculin skin test.The performance and limitation of T-SPOT.TB for the diagnosis of TB in a high prevalence settingIn vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.Tuberculous meningoencephalitis associated with brain tuberculomas during pregnancy: a case reportTuberculosis screening at the Sainte-Anne Hospital in Paris - results of first and second IGRA.Specificity of a whole blood IGRA in German nursing students.Systematic review of cost and cost-effectiveness of different TB-screening strategies.Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workersPotential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.Peripheral T cell cytokine responses for diagnosis of active tuberculosis.Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study.Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic areaQuantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin testDiagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birthValue of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis.Observational study of QuantiFERON®-TB gold in-tube assay in tuberculosis contacts in a low incidence area.Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube testsNegative effect of smoking on the performance of the QuantiFERON TB gold in tube test.IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatmentScreening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.The BCG World Atlas: a database of global BCG vaccination policies and practices.
P2860
Q24201325-014E2D3E-EE86-4E42-84D7-6074C1253236Q26739001-8A964E30-2C70-44AE-81E0-E55AA5B4F84AQ26780382-EBDAD2D1-BC09-4D8A-99E6-47791524E359Q26823223-80F60C05-778D-46F2-9CA9-08CD777AA3C6Q27021614-67C901E7-5B48-48D6-9BC3-2502A6BF69FEQ28392062-EFC5AEC4-9592-4E50-8D59-12A67E3A594EQ28547313-6CD314DF-54E5-4F55-9DEC-B827A8AF3E39Q28710158-EB98914B-0750-4C51-92E6-612714C4118FQ28729742-74AF79E4-5167-4037-AED7-1DD3BDE58D0AQ28731558-36F9AB19-4979-44C6-B0D7-E3EEDC62F3AAQ30357155-B31C0C88-8BF9-4F94-A2FD-6E347DF51A0CQ30391651-E7A86BE7-D840-4B53-ADCA-5518287CA391Q30412650-327EF953-E0C0-4099-BBC4-058327C1E009Q31139426-D23054AA-10F1-4BE6-BAF4-B72D0D1A8DC4Q33591688-FD5DC7B4-CCD0-4C86-9020-24A711C61124Q33643951-3D9BF890-DCB2-47D5-A0FA-D3E3D5D3B11AQ33730382-56F5EEE8-C8CB-451D-9560-7F8CDF8ED17EQ33758652-2BDBFF95-C75E-43C7-B939-45EC4C3CA179Q33814812-F04C9AF9-C92A-4548-A2F6-29AF79CD622DQ33824247-0E09CB8A-ACA1-48FF-B6E7-B95AC221C228Q33851116-27D7B951-9697-475C-9915-8C0B71CE9B00Q33890563-ACA05C97-F44E-40AC-988F-22E34C6D72D3Q34022308-DBB37456-5A4A-4001-B1FD-408B1571757FQ34036168-4DA6519E-21F7-4395-8946-C2056701DEFEQ34066281-A235AB51-B71D-4939-B635-D1AB0EA76849Q34133162-8C7E4CE9-707E-4BEB-9F68-7B6DEC553AC8Q34241795-92F37D3B-D39E-4809-A3B9-8578DDD094D5Q34257658-9271730D-8A15-4291-88A0-143490CE29DFQ34302593-A061A7BD-ACEF-45B1-954A-A2B482D09FFFQ34351266-D6A4647A-1956-4AC2-9301-72A3B78E175DQ34360363-D0E4CD7E-BB5F-4D44-B7A0-D9CE97025F87Q34369813-20675796-25A6-4772-B883-0592E5D4575BQ34385468-7EE0D437-252E-4144-B363-26A4F7DD4998Q34399197-F7F2BFCB-BC45-4122-A08A-14CE5457E01EQ34412119-5AF2D12B-79F5-4817-9415-76BA92901BA3Q34523794-9C570FA8-CECD-4FF0-8A7A-26579D6B7F0DQ34593096-FB7E873F-34CA-4040-90FF-2A47319BFBC5Q34670617-9CBE51D9-34D5-469B-872E-5727DD30AB84Q34672436-3B8FCC82-18C3-4E26-8FC7-B342EE09FDB5Q34708175-FAC1BAF4-078B-40F1-B55C-8BC4E2B3E656
P2860
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Interferon-γ release assays fo ...... atic review and meta-analysis.
@en
Interferon-γ release assays fo ...... atic review and meta-analysis.
@nl
type
label
Interferon-γ release assays fo ...... atic review and meta-analysis.
@en
Interferon-γ release assays fo ...... atic review and meta-analysis.
@nl
prefLabel
Interferon-γ release assays fo ...... atic review and meta-analysis.
@en
Interferon-γ release assays fo ...... atic review and meta-analysis.
@nl
P2093
P50
P921
P1476
Interferon-γ release assays fo ...... atic review and meta-analysis.
@en
P2093
A Nienhaus
D Manissero
G Bothamley
J P Zellweger
P356
10.1183/09031936.00115110
P50
P577
2010-10-28T00:00:00Z